Nancy Babio Selected Research

Nancy Babio Research Topics

Disease

28	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2023 - 09/2009
17	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 09/2009
16	Overweight 01/2024 - 01/2018
15	Obesity 01/2024 - 05/2012
13	Type 2 Diabetes Mellitus (MODY) 12/2023 - 09/2009
6	Abdominal Obesity 01/2023 - 01/2012
5	Body Weight (Weight, Body) 12/2022 - 01/2020
5	Weight Loss (Weight Reduction) 01/2022 - 01/2019
4	Insulin Resistance 05/2024 - 01/2019
4	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 11/2020
4	Hypertension (High Blood Pressure) 01/2023 - 12/2013
3	Inflammation (Inflammations) 11/2023 - 09/2009
3	Hyperuricemia 10/2022 - 10/2013
3	Atrial Fibrillation 01/2022 - 07/2014
3	Cognitive Dysfunction 08/2021 - 01/2021
3	Neoplasms (Cancer) 06/2021 - 01/2014
3	Dyslipidemias (Dyslipidemia) 01/2019 - 01/2012
3	Hypertriglyceridemia 01/2019 - 01/2013
2	Chronic Disease (Chronic Diseases) 03/2024 - 01/2023
2	Male Infertility (Male Sterility) 06/2023 - 03/2021
2	Bone Resorption 04/2023 - 10/2009
2	Myocardial Infarction 01/2023 - 07/2014
2	Stroke (Strokes) 01/2023 - 07/2014
2	Weight Gain 01/2023 - 01/2021
2	Prediabetic State (Prediabetes) 01/2021 - 01/2019
2	Celiac Disease (Celiac Sprue) 08/2020 - 01/2017
2	Hyperglycemia 01/2019 - 11/2014
2	Diabetes Complications 10/2018 - 11/2015
1	Anemia 10/2023
1	Infertility (Sterility) 06/2023
1	Non-alcoholic Fatty Liver Disease 10/2022
1	Hypercholesterolemia 01/2022
1	Heart Failure 01/2022
1	Colonic Neoplasms (Colon Cancer) 12/2021
1	Leukopenia 06/2021
1	Leukocytosis (Pleocytosis) 06/2021
1	Chronic Renal Insufficiency 01/2021
1	Peripheral Arterial Disease 12/2020

Drug/Important Bio-Agent (IBA)

12	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 01/2012
9	Olive OilIBA 12/2023 - 09/2009
9	HDL CholesterolIBA 01/2022 - 01/2013
7	Triglycerides (Triacylglycerol)IBA 05/2024 - 05/2012
4	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2021
4	PolyphenolsIBA 10/2022 - 11/2019
3	LDL CholesterolIBA 05/2024 - 01/2020
3	Coffee FDA Link 01/2023 - 01/2021
3	Vitamin D FDA LinkGeneric 01/2023 - 06/2021
3	Caffeine (No Doz)FDA LinkGeneric 01/2023 - 01/2021
3	Uric Acid (Urate)IBA 10/2022 - 10/2013
3	SugarsIBA 01/2022 - 01/2016
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 01/2019
2	Lipoproteins (Lipoprotein)IBA 11/2023 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 08/2023 - 09/2022
2	Metformin (Glucophage)FDA LinkGeneric 05/2023 - 01/2021
2	EnzymesIBA 01/2023 - 01/2022
2	CholesterolIBA 12/2022 - 01/2020
2	AntioxidantsIBA 11/2022 - 03/2021
2	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 10/2022 - 01/2020
2	CalciumIBA 12/2021 - 11/2013
2	Folic Acid (Vitamin M)FDA LinkGeneric 03/2021 - 03/2021
2	CreatinineIBA 01/2021 - 10/2009
2	CarbohydratesIBA 01/2020 - 09/2009
2	Dietary Fats (Dietary Fat)IBA 01/2019 - 12/2015
1	perfluorooctaneIBA 03/2024
1	LipidsIBA 01/2024
1	CopperIBA 11/2023
1	Hemoglobins (Hemoglobin)IBA 10/2023
1	Dietary IronIBA 10/2023
1	Blood Proteins (Serum Proteins)IBA 08/2023
1	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2023
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 05/2023
1	Protease Inhibitors (Protease Inhibitor)IBA 05/2023
1	Phytic Acid (Inositol Hexaphosphate)IBA 04/2023
1	flavanoneIBA 01/2023
1	naringeninIBA 01/2023
1	FlavonoidsIBA 01/2023
1	Polychlorinated Dibenzodioxins (TCDD)IBA 01/2023
1	Endocrine DisruptorsIBA 01/2023
1	FuransIBA 01/2023
1	Choline (Choline Chloride)IBA 12/2022
1	Betaine (C.B.B.)FDA Link 12/2022
1	Trace Elements (Biometals)IBA 11/2022
1	SeleniumIBA 11/2022
1	Coumaric AcidsIBA 10/2022
1	HydroxybenzoatesIBA 10/2022
1	phenolic acidIBA 10/2022
1	AcidsIBA 01/2022
1	Branched-Chain Amino AcidsIBA 01/2022
1	Arginine (L-Arginine)FDA Link 01/2022
1	Insulin (Novolin)FDA Link 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	TeaIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	IronIBA 01/2021
1	Drinking WaterIBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 11/2020

Therapy/Procedure

27	Mediterranean Diet 11/2023 - 09/2009
3	Glycemic Control 01/2021 - 01/2019
1	Obesity Management 02/2021